New UK drug pricing plans ‘delayed’
October 7, 2013Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP
1,100 jobs to go as Ben Venue confirms closure of Bedford unit
October 7, 2013Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, FDA
Boehringer Ingelheim is calling time on its troubled facility in Ohio operated by Ben Venue Laboratories and says it will …
EMA gets first line Arzerra submission
October 7, 2013Sales and Marketing Arzerra, GSK, Genmab, blood cancer
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the European Medicines Agency (EMA) in a first line …
‘Kick in the teeth’ for NHS
October 7, 2013Sales and Marketing Hunt, NHS, burnham
The UK Labour party has hit back at a government move to scrap a 1% pay rise for more than …
Labour may sue Hunt over ‘cover-up’ tweet
October 7, 2013Medical Communications, Sales and Marketing Hunt, Labour, NHS, Twitter, cover up
The Labour Party is considering suing the health secretary Jeremy Hunt over an alleged libellous Twitter post made on the …
Manufacturing facilities news in brief
October 7, 2013Manufacturing and Production Capsugel, Fujifilm Diosynth Biotechnologies, Pfizer, Purdue Pharma, Warner Chilcott
New facilities, plant shutdowns and layoffs in the pharma manufacturing sector.
SHL reaches a new milestone of 2000 employees in Taiwan
October 7, 2013Manufacturing and Production auto injector, roger samuelsson, shl growth, shl milestone
SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, officially announced reaching a new milestone …
Pharma blogs: going beyond the press release?
October 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, blogs, press releases, social media
The rise of personal blogging has grown in the past decade with millions taking to the internet to tell their …
Daiichi Sankyo hires two new executives
October 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo
Daiichi Sankyo has appointed Glenn Gormley to be its corporate president and chairman, and Greg Barrett as a new acting …
J&J partners with European biotech firms
October 4, 2013Research and Development, Sales and Marketing J&J, JJ, effimune, life sciences, merus
The London Johnson & Johnson Innovation Centre has teamed up with several biotech partners from the European region. Announced at …
Brintellix ‘yes’ from FDA
October 4, 2013Sales and Marketing FDA, Lundbeck, Takeda, brintellix
Takeda Pharmaceutical Company and Lundbeck are celebrating after the FDA approved their depression treatment Brintellix – despite there being no …
Lilly plans trio of launches
October 4, 2013Research and Development, Sales and Marketing lilly, pipeline
Lilly plans to launch at least three new medicines next year, senior managers announced during a meeting with analysts and …
Porter Novelli hires deputy managing director
October 4, 2013Medical Communications, Sales and Marketing Porter Novelli
PR firm Porter Novelli has announced that Fenella Grey has been named as its deputy managing director. Grey joined the …
Global cancer crisis flagged in report
October 3, 2013Medical Communications, Research and Development, Sales and Marketing IPRI, Roche, wprld prevention alliance
A new report advocates the formation of a major industry-backed initiative to tackle the world’s growing cancer burden. Sponsored by …
More companies join AZ’s BioHub
October 3, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, alderley
Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …
4C Consultants International announces two hires
October 3, 2013Medical Communications, Sales and Marketing
Deesha Majithia and Helen Jones have joined comms agency 4C Consultants International. Majithia joins the firm as a project manager …
NICE U-turn on MabThera
October 3, 2013Sales and Marketing MabThera, NHS, NICE, Roche
NICE is thinking about recommending Roche’s MabThera for a rare autoimmune condition – a move which represents a partial victory …
Merck axes 8,500 more jobs
October 2, 2013Medical Communications, Research and Development, Sales and Marketing Jobs, Merck, R&D, cuts
US shutdown starts to bite – UPDATED
October 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare
Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
